Zimbabwe has declined a substantial American healthcare agreement valued at $367m (272 million pounds) over five years due to the United States' insistence on confidential data.
This rejection was revealed following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official representative later clarified that the United States was requesting health data for research and profit while was unwilling to guarantee the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for more negotiations to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Background
Zimbabwe's decision follows a similar case in Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the safety of Kenyans' health data.
After resuming office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance transparency and responsibility.
According to statements, 16 nations in Africa have to date signed these new agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research with no assurance that the end products would be available to our citizens if a new pandemic arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining frameworks already established via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to manage future pandemics.
"This mechanism is designed to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation could be arranged in a way that respects the independence and interests of each country."
Medical Community Reaction
Medical experts said it acknowledged the official position, but recommended that negotiations need to persist given that much of the nation's Aids initiatives depended on external financing.
"If technical issues arise, including those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group commented.
This impasse highlights the continuing challenges between receiving much-needed foreign assistance and protecting a country's data in an ever more data-driven world.